Navigation Links
Smoking, Glucose Tolerance Level may Increase Rheumatoid Arthritis Risk

Two new studies have found that smoking, low formal level of education and certain metabolic indicators are high risk factors in the development of rheumatoid arthritis (RA).

The study was conducted by a team of researchers led by Dr Ulf Bergstrom at the Malmo University Hospital, Sweden.

As part of the studies, researchers examined people enrolled in the Malmo Diet and Cancer Study (MDCS) between 1991 and 1996 and in a Preventive Medicine Program (PMP) between 1974 and 1992 to study the link between smoking and RA and glucose level as a predictor of RA.

Investigators examined lifestyle factors using a self-administered questionnaire and took glucose tolerance and lipids readings.

Individuals who developed RA after participation in the health surveys were compared to controls without RA from the PMP and MDCS, matched for age, sex and year of screening.

The first study found that smoking and a low level of formal education, such as elementary school education only versus university degree status, might independently increase the risk of developing RA.

The second study highlighted the link between smoking, glucose levels and RA and found that both smoking and glucose levels to be independent predictors of RA.

The authors suggested that factors such as diet and genetics influencing metabolism might play an important part in RA development.

"The determinants for developing RA in any population are clearly complex and often unrelated. These studies help us to add more pieces to the giant jigsaw of risk factors for one of the most common autoimmune diseases, affecting approximately 1% of adults worldwide," Bergstrom said.

"We hope these findings will contribute to better understanding of future RA prevention and treatment. Whilst the glucose tolerance findings contrast with previous studies linking impaired tolerance to established RA, they sugges t that other mechanisms may be important years before RA onset. Our results will pave the way for future debate and research to pinpoint its definitive causes," Bergstrom added.

The findings of the study were presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.


'"/>




Related medicine news :

1. Its Never Too Late to Stop Smoking,Study Finds
2. Stop Smoking, Your Body Will Thank You It
3. After Smoking, Trans Fats Next on New York’s Hit Lis
4. MSU Research Strengthens Link Between Smoking, Pancreatic Cancer
5. Lack of Sleep can Lead Teens to Smoking, Boozing
6. Stop Smoking, Start Living: World No Tobacco Day
7. Treatment For Sleep Apnea Found To Lower Blood Glucose Levels
8. Glucose may support in Cardiac Arrest
9. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
10. Glucose Boosts Memory Retention
11. Glucose Enables Speedy Recovery From Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: